These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8546142)

  • 1. Low-density lipoprotein particle size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysis.
    O'Neal D; Lee P; Murphy B; Best J
    Am J Kidney Dis; 1996 Jan; 27(1):84-91. PubMed ID: 8546142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High density lipoprotein (HDL) particle composition in patients with end stage renal failure (ESRF) on chronic dialysis.
    Lee P; O'Neal D; Murphy B; Best J
    Aust N Z J Med; 1997 Jun; 27(3):285-93. PubMed ID: 9227812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis.
    Dieplinger H; Schoenfeld PY; Fielding CJ
    J Clin Invest; 1986 Apr; 77(4):1071-83. PubMed ID: 3082933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-density lipoprotein subfraction profiles in chronic renal failure.
    Rajman I; Harper L; McPake D; Kendall MJ; Wheeler DC
    Nephrol Dial Transplant; 1998 Sep; 13(9):2281-7. PubMed ID: 9761510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin induces an accumulation of atherogenic lipoproteins during hemodialysis in normolipidemic end-stage renal disease patients.
    Barbagallo CM; Noto D; Cefalù AB; Ganci A; Giammarresi C; Panno D; Cusumano G; Greco M; Di Gaudio F; Averna MR
    Hemodial Int; 2015 Jul; 19(3):360-7. PubMed ID: 25495659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LDL and HDL subclass distribution in patients with end-stage renal diseases.
    Alabakovska SB; Todorova BB; Labudovic DD; Tosheska KN
    Clin Biochem; 2002 May; 35(3):211-6. PubMed ID: 12074829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis.
    Marrs JC; Saseen JJ
    Pharmacotherapy; 2010 Aug; 30(8):823-9. PubMed ID: 20653359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
    Gillett MP; Obineche EN; Khan ST; Abdulle AM
    Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
    Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
    Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of low-density lipoprotein oxidation in patients with familial hypercholesterolemia and in end-stage renal disease patients on hemodialysis.
    Van Tits L; De Graaf J; Hak-Lemmers H; Bredie S; Demacker P; Holvoet P; Stalenhoef A
    Lab Invest; 2003 Jan; 83(1):13-21. PubMed ID: 12533682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherogenic lipoproteins in end-stage renal disease.
    Shoji T; Ishimura E; Inaba M; Tabata T; Nishizawa Y
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S30-3. PubMed ID: 11576918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis].
    Zwolińska D; Szprynger K
    Przegl Lek; 1997; 54(5):320-3. PubMed ID: 9380806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of asymmetric dimethylarginine, nitric oxide and lipid peroxidation markers in patients with end-stage renal disease having peritoneal dialysis treatment.
    Göçmen AY; Sahin E; Koçak H; Tuncer M; Gümüşlü S
    Clin Biochem; 2008 Jul; 41(10-11):836-40. PubMed ID: 18457672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a relationship between small, dense LDL and lipoprotein--associated phospholipase A2 mass in dialysis patients?
    Sönmez D; Fidan Y; Ozcan O; Azak A; Seneş M; Duranay M; Yücel D
    Clin Lab; 2014; 60(9):1431-7. PubMed ID: 25291938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LDL particle size and number compared with LDL cholesterol and risk categorization in end-stage renal disease patients.
    Bowden RG; Wilson RL; Beaujean AA
    J Nephrol; 2011; 24(6):771-7. PubMed ID: 21360474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherogenic lipoprotein phenotype in end-stage renal failure: origin and extent of small dense low-density lipoprotein formation.
    Deighan CJ; Caslake MJ; McConnell M; Boulton-Jones JM; Packard CJ
    Am J Kidney Dis; 2000 May; 35(5):852-62. PubMed ID: 10793019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between plasma and dialysate lipoproteins and apoproteins in patients treated by continuous ambulatory peritoneal dialysis.
    Henkin Y; Neeman Z; Zuili I; Chaimovitz C; Shany S
    Am J Kidney Dis; 1993 Dec; 22(6):829-34. PubMed ID: 8250029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy.
    Islam KN; O'Byrne D; Devaraj S; Palmer B; Grundy SM; Jialal I
    Atherosclerosis; 2000 May; 150(1):217-24. PubMed ID: 10781654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.